Edwards Lifesciences Corporation (EW) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $661.70M; Additional Paid in Capital, Common StockUSD $2.98B; Treasury Stock, Common, ValueUSD $7.67B.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $660.00M; Additional Paid in Capital, Common StockUSD $2.78B; Treasury Stock, Common, ValueUSD $7.51B.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $658.70M; Additional Paid in Capital, Common StockUSD $2.77B; Treasury Stock, Common, ValueUSD $7.09B.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $658.20M; Additional Paid in Capital, Common StockUSD $2.70B; Treasury Stock, Common, ValueUSD $7.05B.
Edwards Lifesciences Corporation Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Noncontrolling Interest, Increase from Business Combination USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Treasury Stock, Retired, Par Value Method, Amount USD | Treasury Stock, Retired, Cost Method, Amount USD | Treasury Stock, Shares, Retired shares | Adjustments to Additional Paid in Capital, Stock Split USD | Treasury Stock, Shares, Acquired shares | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $661.70M | $2.98B | $7.67B | (m) | $-214.60M | $14.86B | $10.62B | $10.72B | 85.10M | 3 month · $54.20M | 3 month · $42.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $660.00M | $2.78B | $7.51B | (m) | $-221.30M | $14.62B | $10.33B | $10.33B | 83.00M | 3 month · $522.20M | 3 month · $45.40M | (m) | 3 month · $15.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $658.70M | $2.77B | $7.09B | $-800.00K | $-238.30M | $14.24B | $10.34B | $10.34B | 78.00M | 12 month · $899.40M | 12 month · $158.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $658.20M | $2.70B | $7.05B | (m) | $-250.40M | $14.15B | $10.21B | $10.21B | 77.50M | 3 month · $543.10M | 3 month · $41.20M | (m) | 3 month · $15.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $657.60M | $2.75B | $6.46B | (m) | $-264.10M | $13.86B | $10.55B | $10.61B | 69.70M | 3 month · $5.50M | 3 month · $37.50M | (m) | 3 month · $31.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $655.90M | $2.65B | $6.45B | (m) | $-254.50M | $13.53B | $10.13B | $10.19B | 69.70M | 3 month · $308.60M | 3 month · $40.20M | (m) | 3 month · $28.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $654.80M | $2.61B | $6.19B | $4.10M | $-244.50M | $13.17B | $10.00B | $10.06B | 66.20M | 12 month · $1.17B | 12 month · $163.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $654.30M | $2.45B | $6.09B | (m) | $-252.50M | $12.78B | $9.55B | $9.61B | 64.50M | 3 month · $1.01B | 3 month · $42.10M | (m) | 3 month · $19.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $653.50M | $2.48B | $5.18B | (m) | $-220.20M | $9.71B | $7.44B | $7.50B | 51.20M | 3 month · $158.10M | 3 month · $43.90M | (m) | 3 month · $13.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $651.80M | $2.38B | $5.02B | (m) | $-233.30M | $9.34B | $7.12B | $7.19B | 49.40M | 3 month · $200.00K | 3 month · $44.60M | (m) | 3 month · $6.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $650.50M | $2.27B | $5.02B | $4.20M | $-242.80M | $8.99B | $6.65B | $6.72B | 49.40M | 12 month · $880.50M | 12 month · $139.40M | 12 month · $72.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $649.90M | $2.21B | $4.58B | (m) | $-250.10M | $8.62B | $6.66B | $6.73B | 43.40M | 3 month · $175.10M | 3 month · $32.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $649.10M | $2.15B | $4.40B | (m) | $-255.50M | $8.24B | $6.38B | $6.45B | 41.20M | 3 month · $7.50M | 3 month · $37.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $647.10M | $2.05B | $4.39B | (m) | $-255.40M | $7.93B | $5.98B | $6.06B | 41.10M | 3 month · $249.50M | 3 month · $38.90M | 3 month · $84.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $646.30M | $1.97B | $4.14B | (m) | $-254.90M | $7.59B | $5.81B | $5.81B | 38.00M | 12 month · $1.73B | 12 month · $126.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $645.70M | $1.91B | $3.28B | (m) | $-256.00M | $7.19B | $6.22B | $6.22B | 26.30M | 3 month · $100.40M | 3 month · $30.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $645.00M | $1.85B | (m) | (m) | $-224.40M | $6.85B | $5.94B | $5.94B | (m) | 3 month · $355.10M | 3 month · $36.20M | (m) | (m) | (m) | $3.18B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 25.20M |
| 2022-03-31 | $0.00 | $642.90M | $1.77B | (m) | (m) | $-186.60M | $6.44B | $5.84B | $5.84B | (m) | 3 month · $405.60M | 3 month · $32.40M | (m) | (m) | (m) | $2.82B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 21.50M |
| 2021-12-31 | $0.00 | $642.00M | $1.70B | $2.42B | (m) | $-157.70M | $6.07B | $5.84B | $5.84B | 17.90M | 12 month · $512.80M | 12 month · $109.30M | (m) | (m) | (m) | $2.42B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 17.90M |
| 2021-09-30 | $0.00 | $641.20M | $1.64B | (m) | (m) | $-155.40M | $5.73B | $5.54B | (m) | (m) | 3 month · $1.80M | 3 month · $26.60M | (m) | (m) | (m) | $2.32B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 17.00M |
| 2021-06-30 | $0.00 | $640.10M | $1.58B | (m) | (m) | $-159.60M | $5.39B | $5.13B | (m) | (m) | 3 month · $111.90M | 3 month · $30.30M | (m) | (m) | (m) | $2.32B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 17.00M |
| 2021-03-31 | $0.00 | $637.50M | $1.50B | (m) | (m) | $-172.40M | $4.90B | $4.66B | (m) | (m) | 3 month · $302.60M | 3 month · $28.20M | (m) | (m) | (m) | $2.21B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 15.70M |
| 2020-12-31 | $0.00 | $636.40M | $1.44B | (m) | (m) | $-161.10M | $4.57B | $4.57B | $4.57B | (m) | 12 month · $625.40M | 12 month · $92.60M | (m) | (m) | (m) | $1.90B | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | 12.10M |
| 2020-09-30 | $0.00 | $635.00M | $1.38B | (m) | (m) | $-157.90M | $4.26B | $4.21B | (m) | (m) | 3 month · $1.40M | 3 month · $23.00M | (m) | (m) | (m) | $1.90B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12.10M |
| 2020-06-30 | $0.00 | $633.50M | $1.32B | (m) | (m) | $-146.10M | $3.93B | $3.84B | (m) | (m) | 3 month · $9.00M | 3 month · $24.80M | (m) | (m) | (m) | $1.90B | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) | 12.10M |
| 2020-03-31 | $0.00 | $218.50M | $1.68B | (m) | (m) | $-152.00M | $4.05B | $3.90B | (m) | (m) | 3 month · $614.80M | 3 month · $23.90M | (m) | (m) | (m) | $1.89B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12.00M |
| 2019-12-31 | $0.00 | $218.10M | $1.62B | (m) | (m) | $-156.00M | $3.74B | $4.15B | (m) | (m) | 12 month · $263.30M | 12 month · $81.30M | (m) | (m) | (m) | $1.28B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9.00M |
| 2019-09-30 | $0.00 | $217.50M | $1.57B | (m) | (m) | $-155.80M | $3.46B | $3.81B | (m) | (m) | 3 month · $1.30M | 3 month · $19.80M | (m) | 9 month · $35.70M | (m) | $1.28B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9.00M |
| 2019-06-30 | $0.00 | $216.90M | $1.51B | (m) | (m) | $-138.20M | $3.19B | $3.50B | (m) | (m) | 3 month · $256.30M | 3 month · $22.30M | (m) | (m) | (m) | $1.28B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9.00M |
| 2019-03-31 | $0.00 | $216.00M | $1.45B | (m) | (m) | $-141.20M | $2.94B | $3.45B | (m) | (m) | 3 month · $5.70M | 3 month · $20.80M | (m) | 3 month · $8.60M | (m) | $1.02B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.60M |
| 2018-12-31 | $0.00 | $215.20M | $1.38B | (m) | (m) | $-138.50M | $2.69B | $3.14B | (m) | (m) | 12 month · $795.50M | 12 month · $71.00M | (m) | 12 month · $-15.30M | (m) | $1.02B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.50M |
| 2018-09-30 | $0.00 | $214.80M | $1.34B | (m) | (m) | $-139.00M | $2.69B | $3.36B | (m) | (m) | 3 month · $93.10M | 3 month · $17.40M | (m) | 9 month · $-24.80M | (m) | $743.40M | (m) | (m) | (m) | 9 month · $0.00 | (m) | (m) | (m) | (m) | 5.70M |
| 2018-06-30 | $0.00 | $214.00M | $1.21B | (m) | (m) | $-150.80M | $2.46B | $3.16B | (m) | (m) | 3 month · $428.30M | 3 month · $19.20M | (m) | 6 month · $-19.20M | (m) | $570.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.80M |
| 2018-03-31 | $0.00 | $213.00M | $1.23B | (m) | (m) | $-121.30M | $2.18B | $3.25B | (m) | (m) | 3 month · $2.10M | 3 month · $18.40M | (m) | 3 month · $-4.60M | (m) | $254.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.30M |
| 2017-12-31 | $0.00 | $212.00M | $1.17B | (m) | (m) | $-132.70M | $1.96B | $2.96B | (m) | (m) | 12 month · $763.30M | 12 month · $61.60M | (m) | 12 month · $8.50M | (m) | $252.10M | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) | 2.30M |
| 2017-09-30 | $0.00 | $211.60M | $1.13B | (m) | (m) | $-142.70M | $1.96B | $3.16B | (m) | (m) | (m) | (m) | (m) | 9 month · $5.70M | (m) | $800.00K | (m) | (m) | 9 month · $2.75B | 9 month · $2.75B | (m) | (m) | (m) | (m) | 10.00K |
| 2017-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 33.60M | (m) | (m) | (m) | (m) |
| 2017-06-30 | $0.00 | $244.70M | $1.27B | (m) | (m) | $-157.80M | $4.33B | $2.94B | (m) | (m) | (m) | (m) | (m) | 6 month · $4.10M | (m) | $2.75B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 33.60M |
| 2017-03-31 | $0.00 | $243.20M | $1.21B | (m) | (m) | $-181.50M | $4.15B | $2.74B | (m) | (m) | (m) | (m) | (m) | 3 month · $2.10M | (m) | $2.67B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 32.80M |
| 2016-12-31 | $0.00 | $242.60M | $1.17B | (m) | (m) | $-198.40M | $3.91B | $2.62B | (m) | (m) | 12 month · $662.30M | 12 month · $56.90M | (m) | 12 month · $6.90M | (m) | $2.50B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 31.00M |
| 2016-09-30 | $0.00 | $242.00M | $1.09B | (m) | (m) | $-171.20M | $3.75B | $2.69B | (m) | (m) | (m) | (m) | (m) | 9 month · $10.10M | (m) | $2.22B | (m) | (m) | 9 month · $0.00 | (m) | (m) | (m) | (m) | (m) | 28.30M |
| 2016-06-30 | $0.00 | $241.00M | $1.02B | (m) | (m) | $-178.70M | $3.61B | $2.47B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.22B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 28.30M |
| 2016-03-31 | $0.00 | $239.80M | $933.40M | (m) | (m) | $-172.60M | $3.48B | $2.30B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.18B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 27.90M |
| 2015-12-31 | $0.00 | $239.10M | $946.80M | (m) | (m) | $-182.60M | $3.34B | $2.50B | (m) | (m) | 12 month · $280.10M | 12 month · $49.90M | (m) | 12 month · $65.70M | (m) | $1.84B | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | 23.70M |
| 2015-09-30 | $0.00 | $130.20M | $1.00B | (m) | (m) | $-169.20M | $3.20B | $2.42B | (m) | (m) | (m) | (m) | (m) | 9 month · $49.10M | (m) | $1.74B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 22.50M |
| 2015-06-30 | $0.00 | $129.90M | $964.10M | (m) | (m) | $-146.60M | $3.08B | $2.29B | (m) | (m) | (m) | (m) | (m) | 6 month · $29.10M | (m) | $1.74B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 22.50M |
| 2015-03-31 | $0.00 | $129.40M | $925.00M | (m) | (m) | $-147.90M | $2.97B | $2.21B | (m) | (m) | (m) | (m) | (m) | 3 month · $10.30M | (m) | $1.66B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 21.90M |
| 2014-12-31 | $0.00 | $128.90M | $878.40M | (m) | (m) | $-100.90M | $2.84B | $2.19B | (m) | (m) | 12 month · $300.90M | 12 month · $48.30M | (m) | 12 month · $7.00M | (m) | $1.56B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 4.40M | (m) | 21.10M |
| 2014-09-30 | (m) | $128.00M | $810.00M | (m) | (m) | $-70.60M | $2.73B | $2.04B | (m) | (m) | (m) | (m) | (m) | 9 month · $5.10M | (m) | $1.56B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 21.10M |
| 2014-06-30 | (m) | $127.10M | $747.40M | (m) | (m) | $-41.10M | $2.64B | $1.91B | (m) | (m) | (m) | (m) | (m) | 6 month · $7.70M | (m) | $1.56B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 21.10M |
| 2014-03-31 | (m) | $126.40M | $711.70M | (m) | (m) | $-32.40M | $2.09B | $1.34B | (m) | (m) | (m) | (m) | (m) | 3 month · $5.00M | (m) | $1.56B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 21.10M |
| 2013-12-31 | (m) | $126.00M | $671.20M | (m) | (m) | $-27.60M | $2.03B | $1.54B | (m) | (m) | 12 month · $497.00M | 12 month · $47.40M | (m) | 12 month · $20.50M | (m) | $1.26B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 6.80M | (m) | 16.70M |
| 2013-09-30 | (m) | $125.70M | $618.00M | (m) | (m) | $-42.90M | $1.97B | $1.44B | (m) | (m) | (m) | (m) | (m) | 9 month · $18.30M | (m) | $1.23B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 16.30M |
| 2013-06-30 | (m) | $125.40M | $615.10M | (m) | (m) | $-48.00M | $1.89B | $1.58B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.01B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 13.20M |
| 2013-03-31 | (m) | $124.70M | $587.20M | (m) | (m) | $-52.00M | $1.80B | $1.59B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $866.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 11.20M |
| 2012-12-31 | (m) | $124.20M | $489.00M | (m) | $-20.50M | $-37.90M | $1.65B | $1.47B | (m) | (m) | 12 month · $353.20M | 12 month · $42.10M | (m) | 12 month · $11.30M | (m) | $749.90M | $-25.80M | $1.40M | (m) | (m) | (m) | (m) | 12 month · 4.00M | $7.00M | 9.90M |
| 2012-09-30 | (m) | $123.90M | $458.80M | (m) | (m) | $-37.10M | $1.56B | $1.54B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $572.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.90M |
| 2012-06-30 | (m) | $123.00M | $418.00M | (m) | (m) | $-51.00M | $1.49B | $1.43B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $549.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.70M |
| 2012-03-31 | (m) | $121.10M | $363.30M | (m) | (m) | $-24.60M | $1.43B | $1.39B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $495.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.10M |
| 2011-12-31 | (m) | $120.00M | $300.50M | (m) | $-14.50M | $-37.50M | $1.36B | $1.33B | (m) | (m) | 12 month · $303.80M | 12 month · $35.00M | (m) | 12 month · $-27.70M | (m) | $405.80M | $-30.00M | $1.10M | (m) | (m) | (m) | (m) | 12 month · 3.90M | $5.90M | 5.90M |
| 2011-09-30 | (m) | $119.50M | $326.50M | (m) | (m) | $-23.20M | $1.30B | $1.35B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $365.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 5.30M |
| 2011-06-30 | (m) | $118.80M | $291.40M | (m) | (m) | $-9.50M | $1.25B | (m) | $1.39B | (m) | (m) | (m) | (m) | (m) | (m) | $261.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.90M |
| 2011-03-31 | (m) | $117.70M | (m) | (m) | (m) | $-15.50M | $1.19B | (m) | $1.36B | (m) | (m) | (m) | (m) | (m) | $246.00M | $178.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.90M |
| 2010-12-31 | (m) | $117.00M | $211.30M | (m) | $-8.60M | $-42.10M | $1.12B | $1.31B | $1.31B | (m) | 12 month · $200.00M | 12 month · $29.30M | (m) | (m) | $211.30M | $102.00M | $-24.80M | $2.20M | (m) | (m) | (m) | (m) | (m) | $-10.90M | 2.00M |
| 2010-09-30 | (m) | $116.10M | (m) | (m) | (m) | $-24.20M | $1.06B | (m) | $1.23B | (m) | (m) | (m) | (m) | (m) | $184.40M | $102.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.00M |
| 2010-06-30 | $0.00 | $115.10M | (m) | (m) | (m) | $-53.00M | $1.01B | (m) | $1.12B | (m) | (m) | (m) | (m) | (m) | $145.80M | $101.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.00M |
| 2009-12-31 | $0.00 | $76.10M | (m) | (m) | $-2.90M | $-7.90M | $906.00M | $1.16B | $1.16B | (m) | 12 month · $95.50M | 12 month · $28.30M | (m) | (m) | $1.06B | $872.30M | $100.00K | $-1.00M | (m) | (m) | (m) | (m) | (m) | $-4.10M | 19.30M |
| 2008-12-31 | (m) | (m) | (m) | (m) | $-11.90M | $-35.40M | (m) | $878.80M | $878.80M | (m) | 12 month · $306.50M | 12 month · $28.70M | (m) | (m) | (m) | (m) | $-17.20M | $-5.70M | (m) | (m) | (m) | (m) | (m) | $-600.00K | (m) |
| 2007-12-31 | (m) | (m) | (m) | (m) | $-1.50M | $7.50M | (m) | (m) | $835.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $7.00M | $7.50M | (m) | (m) | (m) | (m) | (m) | $-5.50M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |